OverviewSuggest Edit
Vara is a company that develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. The company also provides remote mammography reading services.
| Type | Private | |
| Founded | 2018 | |
| Website | varahealthcare.com |
Latest Updates
| Employees (est.) (Nov 2020) | 29 | (-3%) |
| Cybersecurity rating | A | More |
Vara Financials and Metrics
Summary Metrics
Founding Date | 2018 |
Vara total Funding | $10.4 m |
Vara latest funding size | $7 m |
Time since last funding | 6 months ago |
Vara investors | OMERS Ventures, PLUG & PLAY, Think.Health, Soleria Capital, Merantix |
Vara's latest funding round in June 2020 was reported to be $7 m. In total, Vara has raised $10.4 m
Vara Cybersecurity Score
Vara Online and Social Media Presence
Vara's Trends
Vara News and Updates
June 03, 2020
Berlin-based Vara raises €6.5 million for AI breast cancer screening software that reduces doctor workload
Vara, a Berlin-based startup that’s developed breast cancer screening software, has raised a €6.5 million Series A round led by OMERS Ventures. Merantix, Think.Health, Soleria Capital, and Silicon Valley-based Plug and Play also participated. Bryony Marshall of OMERS Ventures will join the board.
Vara Frequently Asked Questions
When was Vara founded?
Vara was founded in 2018.
How many employees does Vara have?
Vara has 29 employees.
Who are Vara competitors?
Competitors of Vara include LungLife AI, PinPoint Data Science and AI Medical Service.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies